Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 [iu] - suspension for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 [iu] excipient: hydrochloric acid methyl hydroxybenzoate sodium acetate trihydrate sodium chloride sodium hydroxide water for injection zinc

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml - suspension for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml excipient: hydrochloric acid methyl hydroxybenzoate sodium acetate trihydrate sodium chloride sodium hydroxide water for injection zinc as chloride, approx.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - insulin glulisine, quantity: 3.49 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; metacresol; polysorbate 20; trometamol; hydrochloric acid; sodium hydroxide - apidra is indicated for the treatment of type 1 and type 2 diabetes mellitus in adults and children of 4 years or above who require insulin for the control of hyperglycaemia.

Unió Europea - anglès - EMA (European Medicines Agency)

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin -

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: sodium hydroxide; glycerol; metacresol; zinc oxide; phenol; dibasic sodium phosphate heptahydrate; protamine sulfate; hydrochloric acid; water for injections - this product accepted for registration as 'currently supplied' at the time of commencement of the act. humulin is indicated for the treatment of insulin-dependent diabetic patients.

Canadà - anglès - Health Canada

eli lilly canada inc - insulin injection human biosynthetic; insulin isophane human biosynthetic - suspension - 30unit; 70unit - insulin injection human biosynthetic 30unit; insulin isophane human biosynthetic 70unit - insulins

Canadà - anglès - Health Canada

novo nordisk canada inc - insulin injection human biosynthetic; insulin isophane human biosynthetic - suspension - 30unit; 70unit - insulin injection human biosynthetic 30unit; insulin isophane human biosynthetic 70unit - insulins

Canadà - anglès - Health Canada

wockhardt uk limited - insulin isophane injection pork - suspension - 100unit - insulin isophane injection pork 100unit - insulins

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin detemir, quantity: 100 u/ml - injection, solution - excipient ingredients: glycerol; sodium hydroxide; dibasic sodium phosphate dihydrate; water for injections; hydrochloric acid; zinc acetate; metacresol; phenol; sodium chloride - treatment of diabetes mellitus. (see 'pharmacology' and 'clinical trials.')